Search results
China OKs Novo Nordisk's Type-2 diabetes treatment to enter its market
Reuters· 13 hours agoChina's National Medical Products Administration has granted green lights for Novo Nordisk's insulin...
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
Zacks via Yahoo Finance· 14 hours agoImportance of SECURE-T2D Pivotal Trial Outcome The study results revealed glycemic improvements...
Intermittent Fasting Can Help People With Type 2 Diabetes Control Blood Sugar, Weight Loss
Healthline via AOL· 3 days agoResearchers randomly assigned people recently diagnosed with type 2 diabetes to 16 weeks of ...
Inhaled Insulin Plus Degludec an Option for Type 1 Diabetes
Medscape· 2 days agoThe inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin ...
I lost 42 pounds with Ozempic, but was shaken by the drug's psychological toll
TODAY via Yahoo News· 4 days agoJohann Hari still remembers the strange sensation he felt two days after he first injected himself...
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes...
Benzinga· 9 hours agoThe results were presented at a symposium at the American Diabetes Association's® (ADA) 84th Scientific Sessions in Orlando, FL, and were simultaneously published...
The surprising side effect of Ozempic: Less alcohol use
WFLA via Yahoo News· 6 days agoTAMPA (BLOOM) – In an unexpected twist, patients taking Ozempic, a medication primarily prescribed...
Updated Guideline Reflects New Drugs for Type 2 Diabetes
Medscape· 7 days agoThe American College of Physicians updated its existing guidelines to incorporate evidence on the...
Can Metformin Cause Hair Loss?
MediaFeed via AOL· 14 hours agoMetformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this medication, the ...
Teva launches generic version of Novo Nordisk's diabetes drug Victoza
Reuters via Yahoo News· 11 hours agoBut demand for Victoza, a first-generation GLP-1, has been on a decline with the loss of patent...